Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VAC BNO 1095 in Cyclic Mastodynia and PMS
NCT01309113Phase 3Completed
- Sponsor
- Bionorica
- Start
- Mar 2011
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of vitex agnus-castus fruit extract in Cyclical Mastalgia and premenstrual syndrome (PMS) (3 arms), sponsored by Bionorica. Primary endpoint: Change in maximum severity of cyclic breast pain from baseline to visit 3 at 22 weeks. Started Mar 2011; status: completed.
02
Drugs
vitex agnus-castus fruit extract
03
Conditions
Cyclical Mastalgiapremenstrual syndrome (PMS)
Beyond the preview
Go deeper on NCT01309113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01309113.